Empowering mental health professionals with peer-reviewed psychiatric research and insights

Page 37

More JCP Articles

JCP
Defining and Achieving Treatment Recovery in Schizophrenia
JCP
Atomoxetine and Prevalence of Major Congenital Malformations
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ January 16, 2023

Little is known about the safety of atomoxetine, a non-stimulant treatment for attention-deficit/hyperactivity disorder. This study assessed the prevalence of major congenital malformations after first-trimester exposure to atomoxetine.
JCP
Community Navigation Service for People With Serious Mental Illness
JCP
Actualizing and Sustaining Recovery-Oriented Care
JCP
Cognitive Impairment, Reward Pathways and Treatment Challenges in Schizophrenia Video
JCP
Treating Schizophrenia: Side Effects and Adherence Video
JCP
Sequencing Therapy in the Treatment of Schizophrenia Video
JCP
Shared Decision Making in Schizophrenia Treatment Video
JCP
TMS in Anxious Depression
JCP
A Message of Appreciation From the Editor
JCP
Risk of PNAS in SGA-Exposed Infants
JCP
Peer-Delivered CBT Workshops for Postpartum Depression